Abstract
A 70-year-old woman underwent a renal biopsy due to nephrotic syndrome. She had suffered from nontuberculous mycobacterial infection (NTM) for 14 years. The patient was diagnosed as having membranoproliferative glomerulonephritis (MPGN) type 3 and immunoglobulin (Ig)-associated MPGN based upon LM/erythromycin and IF findings, respectively. In high-magnification imaging, electron-dense deposits showed immunotactoid glomerulopathy (ITG). There was no evidence of hematological cancer, and the patient improved after receiving treatments for NTM. To the best of our knowledge, this patient is the first to show an association between ITG and NTM. Although ITG is generally considered as related to lymphoproliferative disease, it is suggested that ITG is driven by bacterial infection and is a potential outcome of Ig-associated MPGN.
Introduction
While idiopathic membranoproliferative glomerulonephritis (MPGN) is generally limited to children and juveniles, secondary MPGN is common among the elderly [1]. Secondary MPGN is derived from various diseases, including hepatitis B or C, cryoglobulinemia, systemic lupus erythematosus (SLE), Sjögren’s syndrome, and paraprotein deposition diseases [2]. Using erythromycin (EM), MPGN can be classified into MPGN type 1, type 2, and type 3. The discovery of the role of complement in generating glomerulonephritis led to the development of a novel classification of MPGN, which was based on pathophysiology and immunofluorescence in renal biopsy specimens [3-5]. In these criteria, MPGN is divided into immunoglobulin (Ig)-associated MPGN and C3 glomerulopathy (C3-G).
Herein, we present a case of a 70-year-old woman with nephrotic syndrome during nontuberculous mycobacterial infection (NTM). LM and EM of renal biopsy specimen findings led to the diagnosis of MPGN type 3 and IF suggested Ig-associated MPGN. In an ultrastructural survey, the electron-dense deposits (EDDs) revealed that the patient had immunotactoid glomerulopathy (ITG). MPGN associated with mycobacterial infection is rare, and this case is the first report of ITG with NTM.
Case
A 70-year-old woman was admitted to the Juntendo University Shizuoka Hospital for renal biopsy. She consulted in our outpatient clinic 2 years ago due to proteinuria and microscopic hematuria. Although she was treated with angiotensin II receptor antagonist (losartan, 25 mg/day), the urinary protein excretion level increased to the nephrotic range, and pretibial pitting edema was observed.
The patient had suffered from NTM for 14 years. Cultures of gastric lavage samples were positive for Mycobacterium intracellulare. Since she developed toxic epidermal necrolysis after the administration of 3 antituberculosis drugs (isoniazid, rifampicin, and ethambutol), antimycobacterial treatment was suspended.
At the time of admission, the patient was an alert, well-developed, slender woman appearing her stated age. She complained that she became easily fatigued due to marked pitting edema in the lower extremities. The patient did not drink alcohol or smoke. Her blood pressure in the sitting position was 138/94 mm Hg, and the pulse rate was 70 beats per minute. Urinalysis showed a 3+ dipstick test for protein, 2+ for occult blood, and was negative for sugar. Urinary sediments showed 20–29 RBCs/HPF. The urinary protein-to-creatinine ratio was 9.9 g/g Cr. Laboratory tests revealed serum urea nitrogen 24.7 (normal values: 9–21) mg/dL, creatinine 1.43 (normal range: 0.4–0.9) mg/dL, uric acid 7.3 (normal range: 3.8–7.5) mg/dL, and an eGFR of 28.6 mL/min/1.73 m2 (based upon the serum creatinine). The hematologic evaluation, liver function, serum cholesterol, and electrolytes were within normal ranges. Serological markers for syphilis and hepatitis B and hepatitis C were all negative. Serum immunoelectrophoresis revealed normal IgG, IgA, and IgM precipitin arcs. Tests for antinuclear antibodies, anti-DNA antibodies, PR3-ANCA, MPO-ANCA, and anti-glomerular basement membrane antibodies were negative. Testing for cryoglobulins was also negative. The C3 and C4 levels were within normal ranges (Table 1). Small nodular opacities were observed in chest radiography, and multiple small nodules and multifocal bronchiectasis with small cavities were observed in computed tomography imaging (Fig. 1a, b).
During renal biopsy, 3 cores were obtained by ultrasound-guided needle biopsy. The renal cortex was approximately 70%. LM showed 21 glomeruli that exhibited mesangial widening and thickening of capillary walls. Lobular accentuation was evident in the glomeruli, and the capillary lumens were collapsed. Parts of the lobular centers were sclerosed. The glomerular basement membrane was thickened, resulting in double contour appearance. Subepithelial deposition was evident (Fig. 2a, b). Two glomeruli were sclerosed globally, and focal tubular atrophy with interstitial fibrosis and inflammatory cell infiltration were observed in 30% area of the cortex (Fig. 2c). Congo red staining of the renal tissues was negative for amyloid deposition (Fig. 2d). In IF, granular deposits of C3 and C1q were observed in the glomerular mesangial areas and capillary walls. Rather scant IgG and IgM deposits were mainly evident in the capillary walls (Fig. 3). IgA and fibrinogen showed subtle or negative signals. EM showed marked evidence of massive EDDs in the subendothelial areas and mesangial interposition (Fig. 4a). EDDs were observed in the glomerular capillary walls and subepithelial areas. The foot processes over the EDDs were effaced (Fig. 4b, c). High-magnification views revealed that the EDDs were composed of microtubules with a diameter around 50 nm. These tubules formed parallel arrays (Fig. 4d). Immunohistochemistry with anti-DnaJ homolog subfamily B member 9 (DNAJB9) antibody, which specifically stains glomerular deposits in the patients with fibrillary glomerulonephritis, revealed background signals in glomeruli, while human exocrine glands in resected pancreas showed strongly positive signals (Fig. 4e, f) [6, 7]. The findings led to the conclusion that this case was the Burkholder variant of MPGN type 3 or IgG- and C3-positive (immune complex-associated) MPGN by LM and IF [5]. The Congo red staining, immunohistochemistry with anti-DNAJB antibody, and EM findings led to the diagnosis of immunotactoid ITG [8].
M. intracellulare genomic DNA was not detectable in renal tissues from the formalin-fixed, paraffin-embedded biopsy slides using PCR targeting the 16S internal transcribed spacer region [9] (Fig. 4g). The pulmonologist who treated the patient administered an antibacterial agent since her breathing condition and chest X-ray worsened after the renal diagnosis was obtained. The urinary protein excretion level decreased gradually to 3.3 g/gCr, and the rate of elevation of serum creatinine was slower (Fig. 5). Although she had previously experienced allergic reactions against antibacterial agents, her renal function remained stable by adjusting her administration.
Discussion
Immune complex-associated MPGN occurs most commonly due to hepatitis B or C viral infection, which drives persistent antigenemia and immune complex formation [4, 10]. In addition to other viruses, MPGN can be caused by infectious agents, including those of bacterial origin, as in shunt nephritis and endocarditis, and protozoal diseases of malaria and schistosomiasis [11, 12]. MPGN is caused by circulating immune complexes associated with autoimmune diseases including mixed cryoglobulinemia, SLE, Sjögren’s syndrome, and scleroderma [5, 13]. Deposition of monoclonal Igs in the glomerular capillary walls and mesangial areas is another cause of immune complex-associated MPGN. Monoclonal [14] immune complex-associated MPGN can arise after mycobacterial infection [15, 16]. While most of such cases are tuberculosis, only 1 case with NTM has been reported in Japan. In this case, AA amyloid deposition was observed in the stomach, colon, and renal tissues [17]. Since the amyloid fibrils are derived from N-terminal cleavage fragments of the hepatic acute-phase reactant serum amyloid A protein, at least 2 types of proteins from different origins can become deposited in the glomeruli [18].
A recent study by Nasr et al. [19] divided ITG into 2 groups: monoclonal ITG and polyclonal ITG. Our patient is suggested as polyclonal ITG by kappa and lambda light-chain staining (Fig. 2e, f). The IF shows C3 and C1q depositions were dominant in the mesangial area and weak signals of IgG and IgM along the capillary walls while whole signals are subtle. Although deposited types of Igs and complements follow the summarized data in Nasr’s study, the cause of weak fluorescence intensity and distributive difference in glomeruli between Igs and complements are uncertain [19]. During polymerization into microtubules, it is possible that the precursor proteins were chemically or structurally modified.
ITG is defined by the glomerular deposition of microtubules that have distinct hollow centers, which can range in size from 10 to 90 nm [20, 21]. Proteomic analyses have revealed that Ig light- or heavy-chain C regions predominate in ITG [22]. The incidence of serum or urine monoclonal gammopathy is 67%, and serum monoclonal M spike is detected 63% of patients with ITG [23, 24]. Among the 16 patients with ITG, hematologic cancer was diagnosed in more than 35% of patients [24]. Moreover, association with paraprotein is widely discussed, and SLE or HCV infections are listed among the causal illnesses of ITG [25].
While there have been no cases of ITG associated with NTM, there has been 1 case associated with tuberculosis [26]. This 37-yr-old male patient exhibited proteinuria in the nephrotic range (4.8 g/day) and stage G3a CKD. After undergoing antitubercular treatment, proteinuria decreased to 1.1 g/day, but the CKD progressed to stage G4 [27]. Both patients exhibited similar responses to antibacterial treatment and clinical courses. It is difficult to prove whether mycobacterial infection per se caused ITG; however, its treatment did result in partial remission.
As direct evidence of the causal role of infectious agents has not been reported previously, a genomic fragment of M. intracellulare was not detected in our patient’s renal biopsy specimen [15-17, 26, 27]. Considering the pathophysiology of immune complex-associated MPGN or paraprotein deposition diseases, including amyloidosis, cryoglobulinemia, and ITG massive chronic Ig production, are common. Most of the cases led to partial recovery after the treatments of the associated infection. Thus, while infection induces the formation of primary immune complexes, their mass and properties might gradually become virulent under prolonged inflammatory circumstances.
EM provides useful diagnostic information in nearly half of native renal biopsies [27]. It is impossible to differentiate ITG from immune complex-associated MPGN without EM findings. Ultrastructural examination of EDDs was essential for precise diagnosis in this case.
Conclusion
Our patient is the first association of ITG with NTM. Although the relationships between ITG and lymphoproliferative disorders are weighted for discussion, mycobacterial infection including tuberculosis and NTM should be considered as a causal disease of ITG. ITG is a possible outcome of Ig-associated MPGN.
Acknowledgements
We are indebted to the nephrologists, nursing staff, staff in the laboratory of pathology, and the patient at the Juntendo University Shizuoka Hospital for their collaboration and participation in this study. Ayumi Kurusu achieved excellent performance for immunohistochemistry.
Statement of Ethics
This study was approved by the Ethics Committee of the Juntendo University Shizuoka Hospital. Written informed consent was obtained from the patient.
Conflict of Interest Statement
The authors have no conflicts of interests to declare.
Funding Sources
This study was supported by JSPS KAKENHI (grant numbers 26461238 and 17K09039). Shizuoka Medical Research Center for Disaster, Juntendo University, is supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2015–2019 and Juntendo University. The authors have no conflicts of interest to declare.
Author Contributions
Y.S., K.W., H.I., C.K., S.S., T.O., R.W., and T.I. were responsible for the clinical management of the patient and preparing the draft version of this manuscript. H.M. presented a specimen of human-resected pancreas for positive control of anti-DNAJB9 antibody staining. Y.T. and Y.S. contributed to the review of the literature. All authors participated in the writing of the manuscript and read and approved the final version.